# DESCRIPTION

## FIELD OF THE INVENTION

- relate to antibodies with increased half-life

## BACKGROUND OF THE INVENTION

- motivate need for longer half-life in ferrets

## SUMMARY OF THE INVENTION

- introduce modified ferret IgG Fc region
- describe increased half-life in ferrets
- summarize advantages of increased half-life
- provide specific embodiments of invention

## DETAILED DESCRIPTION OF THE INVENTION

### General

- define terms and conventions
- describe general principles and scope

### DEFINITIONS

- define "corresponding" unmodified antibody
- define "epitope"
- define "antibody" and "immunoglobulin"
- define "constant region" and "constant fragment"
- define "Fc region"
- define other terms (e.g. "hinge region", "Fab", "scFv", etc.)

### Amino Acid Substitutions

- describe methods of substituting amino acids
- provide examples of amino acid substitutions

### Antibodies of the Invention

- describe antibodies according to the invention

### Ferret Antibody Derivatives

- define antibody derivatives
- describe conservative amino acid substitutions
- outline chemical modifications of antibodies

### Immunoglobulin Constructs of the Invention

- describe immunoglobulin constructs

### Antibody Preparation

- outline hybridoma technology
- describe phage display methods

### Recombinant Production of Antibodies and Immunoglobulin Constructs

- introduce recombinant production of antibodies
- describe DNA isolation and sequencing
- outline vector components for expression
- discuss promoter and enhancer elements
- describe transcription termination and selection of host cells
- summarize culturing of host cells

### Chimeric Antibodies

- define chimeric antibodies
- describe ferretized and ferret antibodies
- motivate ferretizing non-ferret antibodies
- summarize antibody binding assays
- introduce immunoglobulin fusion proteins
- outline polynucleotides and assays for half-life

## EXAMPLES

### Example 1

- test pharmacokinetics and immune responses

### Example 2

- clone ferret IgG constant region sequences

### Example 3

- prepare chimeric ferret/human antibodies

### Example 4

- clone and express soluble ferret FcRn

### Example 5

- test chimeric mAb binding to ferret FcRn

### Example 6

- evaluate pharmacokinetics of chimeric mAb variants

